Asklepios BioPharmaceutical (AskBio) is a gene therapy company based in Research Triangle Park, North Carolina. Our mission, since our establishment in 2001, has been to advance AAV technology and provide life-changing gene therapy. In late 2020, we became a wholly owned subsidiary of Bayer AG, solidifying our position as a cornerstone of their newly formed Cell & Gene Therapy Platform.

With headquarters in a thriving biotechnology hub, and research and development facilities located globally, we are at the forefront of genetic technology and life-saving gene therapy. Our clinical pipeline includes therapies for central nervous system, neuromuscular, metabolic, and cardiovascular disorders. We are also actively engaged in research initiatives that expand our pipeline for future therapeutics.

With extensive global research collaborations and a portfolio of over 800 patents, we continuously strive to meet the challenges of genetic medicine. Join us in our audacious goal to erase genetic disease and unlock new possibilities for genetic medicine. For more information, simply Ask